🇺🇸 FDA
Pipeline program

sotatercept, PL1 - Powder for injection

A011-13

Phase 3 small_molecule active

Quick answer

sotatercept, PL1 - Powder for injection for Therapeutic confirmatory (phase III) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Therapeutic confirmatory (phase III)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials